Efficacy and Safety of Diclofenac Sodium Gel in Knee Osteoarthritis

Novartis

Status and phase: Completed; Phase 3

Conditions: Osteoarthritis

Treatments: Drug: Diclofenac Topical Sodium Gel 1%

Study type: Interventional

Funder types: Industry

Identifiers

NCT00171626

VOSG-PN-304

Details and patient eligibility

About

This study will test the efficacy and safety of topical diclofenac sodium gel in the treatment of knee osteoarthritis.

Sex: All

Ages: 35+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Key Inclusion criteria

• Osteoarthritis of the knee Key Exclusion criteria
• Other rheumatic disease, such as rheumatoid arthritis
• Active gastrointestinal ulcer during the last year
• Known allergy to analgesic drugs

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind